New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established “proof-of-concept” for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

Rallybio and J&J collaborate to tackle maternal-foetal blood disorder – Pharmaceutical Technology

Share this article With no approved therapies, there is a high unmet need for preventative and prenatal treatments for FNAIT. Credits: fizkes/Shutterstock.com Rallybio has announced

April 13, 2024

Tibetan women’s high-altitude adaptations drive greater reproductive success

Researchers uncover how specific genetic and cardiovascular traits give Tibetan women an edge in surviving and thriving at high altitudes, linking better oxygen delivery to

October 24, 2024

The researchers who resurrected Inrebic are testing a new bone marrow cancer drug in space

It was 4:45 a.m. on May 27. Cat Jamieson, a prominent cancer stem cell researcher, was at her home in San Diego wrapping up a

October 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.